Hippo (HIPO) Q1 2026 Earnings Call Transcript

Hippo delivered Q1 gross written premium of $332 million, up 58% year over year, with net income of $7 million and adjusted net income of $17 million for a fourth straight profitable quarter. The combined ratio improved 60 percentage points to 99.5%, and full-year 2026 guidance was raised for gross written premium to $1.45 billion-$1.525 billion, net written premium to $520 million-$550 million, and adjusted net income to $48 million-$56 million. Management also highlighted a strategic Progressive distribution partnership and early AI gains, including a 30% increase in adjuster efficiency and a 10% improvement in average handle time.

Analysis

The market is likely still underestimating how much of the quarter was mix-quality improvement rather than just cyclical premium growth. A carrier that can compress retention while expanding gross still improving underwriting usually has more pricing power than peers, because it is selectively shedding low-quality capital and redeploying toward better-risk channels; that should widen the valuation gap versus property-heavy insurers over the next 2-4 quarters if loss trends stay stable.

The Progressive relationship is the most important second-order catalyst: it effectively gives HIPO a cheaper, more scalable acquisition funnel without paying for mass brand spend, and it also reduces dependence on any single channel partner. That matters because it can accelerate homeowners growth without forcing the company to loosen underwriting, which is the key credibility check for the next few quarters. If expansion into additional states happens on schedule, the inflection in homeowners can arrive earlier than consensus expects and support a rerating before 2H26.

The biggest hidden lever is expense ratio, not the headline combined ratio. AI-driven claims and service automation should show up first in outsourced-call-center and adjuster productivity lines, but the real upside is operating leverage once volume scales: every point of expense ratio improvement is worth meaningful earnings power, and management’s longer-term margin target implies room for several turns of compression from here. The risk is that AI benefits are front-loaded in efficiency metrics but slower to monetize in GAAP, while catastrophe timing could mask progress for 1-2 quarters.

Contrarian view: the stock may still trade like a turnaround story when the evidence is moving toward a structural compounder. The multi-line mix, tighter partner selection, and underwriting discipline reduce tail risk versus the old single-product narrative, but the market may need one more clean quarter of stable non-CAT loss and retention normalization to believe it. That sets up a favorable asymmetry: if growth accelerates without margin slippage, the rerating could be sharp; if CATs spike or Progressive rollout stalls, the downside is more about timing than thesis failure.

Key Decisions for Investors

• Long HIPO common for 3-6 months on pullbacks: reward/risk improves if the market rerates toward a tech-enabled P&C compounder; use a stop if combined ratio reverts above 103% for two consecutive quarters.
• Add a call spread in HIPO (e.g., 6-9 month tenor) to express upside from Progressive state expansion and AI operating leverage while capping premium spend; best if implied vol stays below realized vol.
• Pair trade: long HIPO / short a property-heavy insurer or homeowners-exposed peer over the next 1-2 quarters to isolate mix diversification and AI efficiency as the differentiator.
• Buy PGR on any weakness as a distribution-enablement beneficiary if the partnership proves scalable; downside is limited, upside comes from incremental channel monetization and cross-distribution optionality.
• Avoid shorting on headline profitability; if you want to fade, wait for evidence of adverse CAT seasonality or slower Progressive rollout rather than preemptively betting against the operating leverage story.